ArticleJapanese journal of clinical oncology2024

Baseline characteristics may impact treatment duration of cabazitaxel in patients with mCRPC: a subanalysis of data from a post-marketing surveillance.

Nobuaki Matsubara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.